Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors

American Journal of Therapeutics
Alan S RyanEdward B Nelson

Abstract

The cardiovascular benefits of fish-derived long-chain polyunsaturated fatty acids, docosahexaenoic acid (DHA), and eicosapentaenoic acid are well established. Less studied are specific effects of individual long-chain polyunsaturated fatty acids. Based on data from 16 published clinical trials, this review examines effects of DHA triglyceride (TG) oil derived from algae (algal-DHA) on serum TG levels and related parameters. Study populations included subjects with both normal and elevated TG levels including those with persistent hypertriglyceridemia treated with concomitant 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) therapy. At doses of 1-2 g/d, algal-DHA significantly lowered plasma TG levels (up to 26%) either administered alone or in combination with statins. The reduction in TG levels was markedly greater in hypertriglyceridemic than in normal subjects. Algal-DHA modestly increased plasma levels of both high-density lipoprotein and low-density lipoprotein cholesterol. The increased plasma level of low-density lipoprotein cholesterol was associated with a shift of lipoprotein particle size toward larger, less atherogenic subfractions. In some subjects, blood pressure and heart rate were significantl...Continue Reading

References

Nov 22, 1980·Lancet·A HiraiJ Jajiki
Jan 1, 1996·The American Journal of Cardiology·J EritslandM Abdelnoor
Sep 18, 1996·JAMA : the Journal of the American Medical Association·C D GardnerR M Krauss
Apr 10, 1997·The New England Journal of Medicine·M L DaviglusR B Shekelle
Dec 31, 1997·Current Opinion in Lipidology·B Angelin
Jan 10, 1998·JAMA : the Journal of the American Medical Association·C M AlbertJ E Manson
Jan 16, 1998·Prostaglandins, Leukotrienes, and Essential Fatty Acids·J J AgrenG Hornstra
Mar 17, 1999·The Journal of Clinical Investigation·M L KahnS R Coughlin
Apr 10, 2002·JAMA : the Journal of the American Medical Association·Frank B HuJoAnn E Manson
Mar 31, 2004·The American Journal of Clinical Nutrition·Hannah E TheobaldThomas A B Sanders
Oct 16, 2004·Current Atherosclerosis Reports·Trevor A Mori, Lawrence J Beilin
Dec 31, 2004·International Journal of Clinical Pharmacology and Therapeutics·M M EnglerM Mietus-Snyder
Mar 23, 2005·The American Journal of Cardiology·Marguerite M EnglerMichele L Mietus-Snyder
Feb 2, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Katsuyuki NakajimaAkira Tanaka
Feb 16, 2006·Current Opinion in Clinical Nutrition and Metabolic Care·Trevor A Mori, Richard J Woodman
Mar 31, 2006·The British Journal of Nutrition·Julia GeppertBerthold Koletzko
Jan 19, 2007·Journal of the American College of Nutrition·Lisa J SchwellenbachUNKNOWN Clinical Pharmacy Cardiac Risk Service Study Group
Mar 22, 2007·The Journal of Nutrition·Hannah E TheobaldThomas A B Sanders
Aug 9, 2007·The American Journal of Clinical Nutrition·Darshan S KelleyBruce E Mackey

❮ Previous
Next ❯

Citations

Mar 1, 2012·The Proceedings of the Nutrition Society·Darshan S Kelley, Yuriko Adkins
Dec 17, 2009·Behavioral Neuroscience·Irina FedorovaNorman Salem
Mar 12, 2011·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Susan SergeantMichelle M Nicolle
Jun 29, 2012·The Journal of Nutrition·Patrice ArmstrongCharles B Stephensen
Oct 17, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Belma SkenderJirina Hofmanova
Aug 16, 2014·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Kevin C MakiJeffrey G Geohas
Feb 7, 2012·Prostaglandins, Leukotrienes, and Essential Fatty Acids·E M Novak, S M Innis
May 4, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Karin Yurko-MauroUNKNOWN MIDAS Investigators
Jan 27, 2012·The Journal of Clinical Hypertension·Mark Houston
Apr 10, 2013·Journal of Proteomics·Krzysztof WrzesinskiAdelina Rogowska-Wrzesinska
Oct 30, 2016·Metabolic Syndrome and Related Disorders·Nirvair S Kelley
May 17, 2015·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Noel W SolomonsNorman Salem
Nov 16, 2013·International Journal of Food Sciences and Nutrition·Elvira VerduciMarcello Giovannini
Feb 19, 2014·Journal of the American College of Nutrition·Stephen T SinatraMiguel A Martinez-Gonzalez
Oct 21, 2010·Reproductive Sciences·Seishi FurukawaTsuyomu Ikenoue
Nov 19, 2011·American Journal of Physiology. Gastrointestinal and Liver Physiology·Elizabeth M NovakSheila M Innis
Feb 11, 2010·Current Opinion in Clinical Nutrition and Metabolic Care
Mar 2, 2010·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
G J WibertC Kelly
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Linda M ArterburnD Kyle
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Linda M ArterburnD Kyle
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Meng-Chuan HuangJ T Brenna
Current Opinion in Clinical Nutrition and Metabolic Care
Trevor A Mori, Richard J Woodman
© 2021 Meta ULC. All rights reserved